Literature DB >> 25664046

Effects of intrathecal anesthesia with different concentrations and doses on spinal cord, nerve roots and cerebrospinal fluid in dogs.

Jianrong Guo1, Na Lv1, Yongjun Su1, Yang Liu1, Jianping Zhang1, Dawei Yang1.   

Abstract

OBJECTIVE: To investigate the effects of intrathecal anesthesia with bupivacaine, levobupivacaine and ropivacaine hydrochloride at different doses on the spinal cord, nerve roots and cerebrospinal fluid (CSF) in dogs.
METHODS: Forty-two mongrel dogs were randomly divided into normal saline group (C; 2 ml), 0.5% (B1) and 0.75% (B2) bupivacaine hydrochloride groups (2 ml), 0.5% (L1) and 0.75% (L2) levobupivacaine hydrochloride group (2 ml), 0.5% (R1) and 0.75% (R2) ropivacaine hydrochloride group (2 ml), and drugs were intrathecally injected.
RESULTS: The contents of Ca(2+) and MDA and SOD activity of the spinal cord were comparable among groups (P > 0.05). In Groups B1, L1 and R1, the neuronal cytoplasm of spinal tissues was basically normal, the majority of mitochondria and endoplasmic reticulum had complete structure, and the lamellar structure of modulated fibers was nearly normal. In Groups B2, L2 and R2, a small amount of mitochondrial vacuolar degeneration was found in the neuronal cytoplasm of spinal cord, but their structures were basically normal; the neural tissues exhibited focal mild edema, and most of the lamellar structure of modulated fibers and Schwann cells were nearly normal except for loose structure in several fibers and cells.
CONCLUSION: When compared with 0.75% anesthetics for local anesthesia, the early adverse effects on the ultrastructure of the spinal cord and nerve root reduce after focal anesthesia with 0.5% anesthetics.

Entities:  

Keywords:  Amides; Ca2+; free radical; intrathecal anesthesia; nerve root; spinal cord; ultrastructure

Year:  2014        PMID: 25664046      PMCID: PMC4307493     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  30 in total

1.  Hydrogen-rich saline protects against spinal cord injury in rats.

Authors:  Chengwen Chen; Qianbo Chen; Yanfei Mao; Shengming Xu; Chunyan Xia; Xueyin Shi; John H Zhang; Hongbin Yuan; Xuejun Sun
Journal:  Neurochem Res       Date:  2010-03-31       Impact factor: 3.996

Review 2.  Local anesthetics: review of pharmacological considerations.

Authors:  Daniel E Becker; Kenneth L Reed
Journal:  Anesth Prog       Date:  2012

3.  Intrathecally administered ropivacaine is less neurotoxic than procaine, bupivacaine, and levobupivacaine in a rat spinal model.

Authors:  Tamie Takenami; Guoqin Wang; Yoshihiro Nara; Sayano Fukushima; Saburo Yagishita; Hiromi Hiruma; Tadashi Kawakami; Hirotsugu Okamoto
Journal:  Can J Anaesth       Date:  2012-03-02       Impact factor: 5.063

4.  Intrathecal lidocaine causes posterior root axonal degeneration near entry into the spinal cord in rats.

Authors:  Tamie Takenami; Saburo Yagishita; Fumio Asato; Masayasu Arai; Sumio Hoka
Journal:  Reg Anesth Pain Med       Date:  2002 Jan-Feb       Impact factor: 6.288

5.  Glutamate release and neurologic impairment after intrathecal administration of lidocaine and bupivacaine in the rat.

Authors:  Chen-Hwan Cherng; Chih-Shung Wong; Ching-Tang Wu; Chun-Chang Yeh
Journal:  Reg Anesth Pain Med       Date:  2011 Sep-Oct       Impact factor: 6.288

6.  Direct neurotoxicity of tetracaine on growth cones and neurites of growing neurons in vitro.

Authors:  S Saito; I Radwan; H Obata; K Takahashi; F Goto
Journal:  Anesthesiology       Date:  2001-09       Impact factor: 7.892

7.  Continuous monitoring of cerebrospinal fluid oxygen tension in relation to motor evoked potentials during spinal cord ischemia in pigs.

Authors:  Jeroen Lips; Peter de Haan; Gert Joan Bouma; Rebecca Holman; Eric van Dongen; Cor J Kalkman
Journal:  Anesthesiology       Date:  2005-02       Impact factor: 7.892

8.  Lithium attenuates bupivacaine-induced neurotoxicity in vitro through phosphatidylinositol-3-kinase/threonine-serine protein kinase B- and extracellular signal-regulated kinase-dependent mechanisms.

Authors:  Z Wang; J Shen; J Wang; T Lu; C Li; X Zhang; L Liu; Z Ding
Journal:  Neuroscience       Date:  2012-01-03       Impact factor: 3.590

9.  In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity.

Authors:  Philipp Lirk; Ingrid Haller; Hans Peter Colvin; Leopold Lang; Bettina Tomaselli; Lars Klimaschewski; Peter Gerner
Journal:  Anesth Analg       Date:  2008-05       Impact factor: 5.108

10.  Evaluation of spinal toxicity and long-term spinal reflex function after intrathecal levobupivaciane in the neonatal rat.

Authors:  Emre Hamurtekin; Bethany L Fitzsimmons; Veronica I Shubayev; Marjorie R Grafe; Ronald Deumens; Tony L Yaksh; Suellen M Walker
Journal:  Anesthesiology       Date:  2013-07       Impact factor: 7.892

View more
  2 in total

Review 1.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

2.  Ropivacaine inhibits proliferation, migration, and invasion while inducing apoptosis of glioma cells by regulating the SNHG16/miR-424-5p axis.

Authors:  Rong Liu; Min Wu; Guiju Xu; Lu Ju; Jinhui Xiao; Wei Zhong; Xiao He; Yan Yang
Journal:  Open Life Sci       Date:  2020-12-31       Impact factor: 0.938

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.